(0.08%) 5 184.93 points
(0.03%) 38 863 points
(-0.09%) 16 335 points
(0.17%) $78.61
(0.68%) $2.21
(-0.35%) $2 323.10
(-0.32%) $27.53
(2.42%) $988.25
(0.17%) $0.930
(0.86%) $10.92
(0.43%) $0.799
(-0.05%) $91.30
0.73% $ 228.70
Live Chart Being Loaded With Signals
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific...
Stats | |
---|---|
Dzisiejszy wolumen | 289 642 |
Średni wolumen | 949 818 |
Kapitalizacja rynkowa | 41.67B |
EPS | $0 ( 2024-05-02 ) |
Następna data zysków | ( $0 ) 2024-07-30 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 31.29 |
ATR14 | $0.127 (0.06%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-01 | Bousbib Ari | Buy | 42 847 | Common Stock |
2024-03-01 | Bousbib Ari | Sell | 16 261 | Common Stock |
2024-03-01 | Bousbib Ari | Sell | 15 417 | Common Stock |
2024-03-01 | Bousbib Ari | Sell | 11 169 | Common Stock |
2024-03-01 | Bousbib Ari | Sell | 42 847 | Stock Appreciation Right |
INSIDER POWER |
---|
4.82 |
Last 100 transactions |
Buy: 392 287 | Sell: 364 416 |
Wolumen Korelacja
IQVIA Holdings Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
NUVB | 0.89 |
ADCT | 0.88 |
BLK | 0.875 |
IVR | 0.866 |
RGS | 0.866 |
SSL | 0.863 |
MYTE | 0.861 |
USDP | 0.858 |
LH | 0.858 |
BARK | 0.857 |
10 Najbardziej negatywne korelacje | |
---|---|
CSLT | -0.824 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
IQVIA Holdings Inc Korelacja - Waluta/Towar
IQVIA Holdings Inc Finanse
Annual | 2023 |
Przychody: | $15.01B |
Zysk brutto: | $4.14B (27.56 %) |
EPS: | $7.39 |
FY | 2023 |
Przychody: | $15.01B |
Zysk brutto: | $4.14B (27.56 %) |
EPS: | $7.39 |
FY | 2022 |
Przychody: | $14.41B |
Zysk brutto: | $5.03B (34.89 %) |
EPS: | $5.82 |
FY | 2021 |
Przychody: | $13.87B |
Zysk brutto: | $4.64B (33.45 %) |
EPS: | $5.05 |
Financial Reports:
No articles found.
IQVIA Holdings Inc
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej